Want to see IL:CANF full AI Analyst Report?
Can-Fite BioPharma (CANF) has received a new Buy rating, initiated by H.C. Wainwright analyst, Swayampakula Ramakanth. Swayampakula Ramakanth has given his Buy rating due to a combination of factors including
...Read more
CANF News on the Web
TipRanks News
Bullish
TipRanks News
Bullish
TipRanks News
Bullish
TipRanks News
Bullish
TipRanks News
Bullish
TipRanks News
Neutral
TipRanks News
Bullish
TipRanks News
Bullish
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is IL:CANF’s Media Buzz Sentiment?
Currently, no data Available
What is IL:CANF’s weekly average amount of articles?
In an average week, 0.5 articles about IL:CANF are published.
What is IL:CANF’s News Sentiment?
Currently, no data Available